Brain Aneurysm Treatment Market to Enlist Popularity rate at ~5.4% of CAGR from 2017 to 2023

Market Research Future
Competition in the Global Brain Aneurysm Treatment Market and are profiled in MRFR Analysis. “Global Brain Aneurysm Treatment Market by Manufacturers, Countries, Type and Application, Forecast to 2023 Report “Provides In-Depth Analysis Of Parent Market Trends, Macro-Economic Indicators And Governing Factors Along With Market Attractiveness As Per Segments.

Market Research Future published new report, titled “Brain Aneurysm Treatment Market-Research Report: Global Forecast till 2023”.

This report provides in depth study of “Brain Aneurysm Treatment Market 2017 Global Industry Research Report focuses on industry chain structure, market Size, Share, opportunities, future roadmap, industry analysis, industry policy analysis, market Leading player profiles and strategies. This New Report presented by Market Research Future contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. Further MRFR asserts that the Market will demonstrate a colossal growth by 2023. Considering all these factors the global Brain Aneurysm Treatment market research report is expected to grow at a CAGR 5.4% during the forecast period of 2017-2023. 

The Worldwide Brain Aneurysm Treatment Market report explores the Top Key Players in-depth analysis as Medtronic Plc., Codman & Shurtleff, Inc., Raumedic AG, Vittamed, Sophysa Ltd., MicroPort Scientific Corporation, Orsan Medical Technologies, and Spiegelberg GmbH, Johnson & Johnson, Sophysa Ltd, HaiWeiKang, Head Sense Medical, InfraScan, Inc., Integra Life Sciences Corporation and others.

Market Highlights

Brain Aneurysm is an abnormal dilation of arteries in the brain which finally results in the weakening of inner muscular layer of the blood vessel wall. Over time, blood flow within the artery starts pushing the thin portion of the wall and ruptures it. The resultant bleeding due to ruptured artery in the brain is called subarachnoid hemorrhage (SAH). This kind of hemorrhage may lead to coma, stroke, and/or death. There are number of factors that contribute to the occurrence of brain aneurysms, such as cigarette smoking, injury or trauma, blood infections, and many others. Individuals harboring a brain aneurysm can be diagnosed by various techniques, such as Computed Tomography (CT) scan, Computed Tomography Angiogram (CTA) scan, Magnetic Resonance Angiography (MRA), cerebral angiogram, and many others.

A number of factors such as, increasing prevalence of brain aneurysms, advancement in surgical techniques, rising occurrence of high blood pressure, and increasing healthcare funding by government bodies are propelling the growth of brain aneurysm treatment market. Presence of brain aneurysm in the family history are also fuelling up the market to a great extent. According to the Brain Aneurysm Foundation, occurrence of familial aneurysms among subarachnoid hemorrhage patients is 6% to 20%. Despite these drivers, there are some issues associated with brain aneurysm treatment market. High cost of management for aneurysmal subarachnoid hemorrhage, and unknown symptoms of unruptured brain aneurysm may hinder the growth of market to an extent. Brain Aneurysm Foundation states that Brain aneurysms are mostly prevalent at the age of 35 – 60 years whereas aneurysmal hemorrhagic stroke is more common in people aged 50 years.

Market Segments:

The brain aneurysm treatment market is segmented on the basis of type, condition, and end-user.

On the basis of type, market is segmented into surgery and medication. Surgery is further classified into surgical clipping, endovascular coiling, flow diverter, and others. Sub-segmentation of flow diverter includes pipeline embolization device, silk flow diverter (SILK), and surpass flow diverter (SURPASS). Sub-segmentation of medication includes anti-seizure medications, analgesics, calcium channel blockers, antihypertensives, antiemetics, antacids, stool softeners, and others.

On the basis of condition, market is classified into unruptured aneurysm and ruptured aneurysm.

On the basis of end-use, market is segmented into hospital, clinics, and others.

GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/4561 .

Regional Analysis:

The Americas dominates the brain aneurysm treatment market owing to the increasing prevalence of brain aneurysm. According to the 2017 study published in Surg Neurol Int., it is found that more than 3% population of the United States i.e. nearly 10 million individuals are living with brain aneurysm.

Europe holds the second largest market for brain aneurysm. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region. Some cerebrovascular conditions are also very prevalent in the European region. According to a research study published in BMJ Open, it is found that Unruptured Intracranial Aneurysms (UIAs) is one of the most common cerebrovascular conditions in Germany. It is also estimated that nearly 1.6 million individuals in Germany are suffering from Unruptured intracranial aneurysms (UIAs).

Asia Pacific is the fastest growing brain aneurysm treatment market owing to the huge patient population and developing healthcare technology.

The Middle East & Africa holds the least share of brain aneurysm treatment market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.

BRIEF TOC:

Chapter 1 Report Prologue

Chapter 2 Market Introduction    
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations

Chapter 3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment

Chapter 5 Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis 

…CONTINUED

GET DISCOUNT @ https://www.marketresearchfuture.com/check-discount/4561 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/brain-aneurysm-treatment-market-4561